Congcong Xu

527 total citations
30 papers, 371 citations indexed

About

Congcong Xu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Congcong Xu has authored 30 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Congcong Xu's work include Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Congcong Xu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Congcong Xu collaborates with scholars based in China, United Kingdom and Japan. Congcong Xu's co-authors include Caixiu Lin, Yanxing Chen, Hao Zhang, Xiang Han, Yan Sun, Yuping Tang, Lei Lv, Qiang Dong, Sheng Feng and Hao Chen and has published in prestigious journals such as Journal of Clinical Oncology, Brain Research and Medicine.

In The Last Decade

Congcong Xu

28 papers receiving 368 citations

Peers

Congcong Xu
Congcong Xu
Citations per year, relative to Congcong Xu Congcong Xu (= 1×) peers Hsu‐Tung Lee

Countries citing papers authored by Congcong Xu

Since Specialization
Citations

This map shows the geographic impact of Congcong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congcong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congcong Xu more than expected).

Fields of papers citing papers by Congcong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Congcong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congcong Xu. The network helps show where Congcong Xu may publish in the future.

Co-authorship network of co-authors of Congcong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Congcong Xu. A scholar is included among the top collaborators of Congcong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Congcong Xu. Congcong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Tianjiao, et al.. (2025). SIRT4 Controls Acetyl-CoA Synthesis to Promote Stemness and Invasiveness of Hepatocellular Carcinoma through Deacetylating MCCC2. International Journal of Biological Sciences. 21(7). 2973–2990. 1 indexed citations
2.
Li, Guolian, Yang Wang, Xing Chen, et al.. (2025). Migratory behavior of Fe\Mn at the suspended particulate matter-water interface on the Yangtze River Basin Scale: Environmental implications and controlling factors. Process Safety and Environmental Protection. 203. 107866–107866.
3.
Gao, Ye, Xin-Yi Tian, Qianping Zhang, et al.. (2024). Inhibition the ubiquitination of ENaC and Na,K-ATPase with erythropoietin promotes alveolar fluid clearance in sepsis-induced acute respiratory distress syndrome. Biomedicine & Pharmacotherapy. 174. 116447–116447. 5 indexed citations
4.
Xu, Congcong, et al.. (2024). Characteristics of Abdominal Fat Based on CT Measurements to Predict Early Recurrence After Initial Surgery of NMIBC in Stage Ta/T1. Clinical Genitourinary Cancer. 22(6). 102199–102199. 2 indexed citations
5.
Wen, Chao, Huan Chen, Hang Lin, et al.. (2024). Per- and polyfluoroalkyl substances inhibit human and rat 17β-hydroxysteroid dehydrogenase 1: Quantitative structure-activity relationship and molecular docking analysis. Ecotoxicology and Environmental Safety. 273. 116173–116173. 7 indexed citations
6.
Lv, Ya, Deming Chen, Xinyi Tian, et al.. (2023). Protectin conjugates in tissue regeneration 1 alleviates sepsis-induced acute lung injury by inhibiting ferroptosis. Journal of Translational Medicine. 21(1). 293–293. 30 indexed citations
7.
Xu, Congcong, et al.. (2023). Protectin DX Relieve Hyperoxia‐induced Lung Injury by Protecting Pulmonary Endothelial Glycocalyx. Journal of Inflammation Research. Volume 16. 421–431. 5 indexed citations
8.
Xu, Congcong, Qipeng Zhang, Jiawei Li, et al.. (2023). Prognosis and surgical outcomes of the total thymectomy versus thymomectomy in non-myasthenic patients with early-stage thymoma: A systematic review and meta-analysis. Asian Journal of Surgery. 46(9). 3455–3463. 3 indexed citations
9.
Xu, Congcong, et al.. (2022). Simvastatin Inhibits NLRP3 Inflammasome Activation and Ameliorates Lung Injury in Hyperoxia‐Induced Bronchopulmonary Dysplasia via the KLF2‐Mediated Mechanism. Oxidative Medicine and Cellular Longevity. 2022(1). 8336070–8336070. 17 indexed citations
10.
Li, Jiawei, Baofu Chen, Xia Wang, et al.. (2022). Prognosis of patients with esophageal squamous cell carcinoma undergoing surgery versus no surgery after neoadjuvant chemoradiotherapy: a retrospective cohort study. Journal of Gastrointestinal Oncology. 13(3). 903–911. 3 indexed citations
11.
Shen, Jianfei, Weitao Zhuang, Congcong Xu, et al.. (2021). Surgery or Non-surgical Treatment of ≤8 mm Non-small Cell Lung Cancer: A Population-Based Study. Frontiers in Surgery. 8. 632561–632561. 8 indexed citations
13.
Xu, Congcong & Hao Chen. (2021). A Ferroptosis-Related Gene Model Predicts Prognosis and Immune Microenvironment for Cutaneous Melanoma. Frontiers in Genetics. 12. 697043–697043. 16 indexed citations
14.
Fu, Guanghou, Anqi Chen, Zhijie Xu, et al.. (2021). Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer. Frontiers in Oncology. 11. 11 indexed citations
15.
Chen, Yanxing, et al.. (2020). TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment. Frontiers in Neuroscience. 14. 602508–602508. 70 indexed citations
16.
Xu, Congcong, et al.. (2019). Tumor Enucleation vs. Partial Nephrectomy for T1 Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 9. 473–473. 18 indexed citations
17.
Lu, Yuan‐Fei, Qian Zhang, Haiyan Chen, et al.. (2019). Optimizing prostate cancer accumulating model: combined PI-RADS v2 with prostate specific antigen and its derivative data. Cancer Imaging. 19(1). 26–26. 6 indexed citations
18.
Xu, Congcong, et al.. (2017). [Efficacy and safety of ultrasound-guided or neurostimulator-guided bilateral axillary brachial plexus block].. PubMed. 97(38). 3005–3009. 1 indexed citations
19.
Xu, Congcong, Hongjun Wei, Wenwen Zhao, et al.. (2013). Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma. Pathology - Research and Practice. 209(8). 479–485. 19 indexed citations
20.
Lv, Lei, Yan Sun, Xiang Han, et al.. (2011). Valproic acid improves outcome after rodent spinal cord injury: Potential roles of histone deacetylase inhibition. Brain Research. 1396. 60–68. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026